Skip to main content
The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study.
- Author(s): Fisher, Lawrence;
- Polonsky, William;
- Asuni, Adijat;
- Jolly, Yasmin;
- Hessler, Danielle
- et al.
Published Web Locationhttps://doi.org/10.1016/j.jdiacomp.2020.107748
AimsTo describe the effects of the COVID-19 pandemic on adults with T1D or T2D in the U.S.
MethodsParticipants, recruited from the Taking Control of Your Diabetes Research Registry, were ≥19 years old and diagnosed with either T1D or T2D for ≥12 months. Participants completed an online survey on a HIPAA-protected platform.
ResultsCompleted surveys were received from 763 T1Ds and 619 T2Ds. Average T1D age was 53.3 (SD = 15.3); average T2D age was 64.9 (SD = 10.3). Both samples were predominantly female, non-Hispanic white and well-educated. Average self-reported HbA1c was 6.9 (SD = 1.0; 52 mmol/mol) for T1Ds and 7.1 (SD = 1.1; 54 mmol/mol) for T2Ds. About 40% of respondents reported that all of their diabetes healthcare appointments at the time were cancelled or postponed, 40% reported a switch to telehealth appointments and almost half reported lower overall satisfaction with these visits (compared to pre-pandemic). There were widespread increases in general and diabetes-related stress and social isolation, and negative effects on disease management. About 25% reported increases in highs, lows, and glucose variability in both groups.
ConclusionThere has been a substantive increase in level of diabetes-related and general life stress and social isolation due to the pandemic, with a significant impact on disease management.
For improved accessibility of PDF content, download the file to your device.